Bank Of New York Mellon Corp Precision Biosciences Inc Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.97 - $45.0 $30,063 - $1.39 Million	30,993 New	30,993 $36,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $174,835 - $507,783	-152,031 Reduced 83.05%	31,037 $50,000
Q1 2022 May 11, 2022	BUY	$2.96 - $7.76 $14,808 - $38,823	5,003 Added 2.81%	183,068 $564,000
Q4 2021 Feb 11, 2022	BUY	$7.4 - $11.66 $38,354 - $60,433	5,183 Added 3.0%	178,065 $1.32 Million
Q3 2021 Nov 12, 2021	BUY	$9.18 - $14.15 $216,969 - $334,435	23,635 Added 15.84%	172,882 $2 Million
Q2 2021 Aug 11, 2021	SELL	$8.07 - $12.52 $199,393 - $309,344	-24,708 Reduced 14.2%	149,247 $1.87 Million
Q1 2021 May 13, 2021	SELL	$8.57 - $15.79 $93,361 - $172,016	-10,894 Reduced 5.89%	173,955 $1.8 Million
Q4 2020 Feb 09, 2021	BUY	$5.98 - $12.47 $70,653 - $147,333	11,815 Added 6.83%	184,849 $1.54 Million
Q3 2020 Nov 12, 2020	BUY	$4.65 - $8.73 $42,212 - $79,250	9,078 Added 5.54%	173,034 $1.07 Million
Q2 2020 Aug 12, 2020	BUY	$4.66 - $8.7 $299,568 - $559,279	64,285 Added 64.5%	163,956 $1.37 Million
Q1 2020 May 06, 2020	BUY	$5.05 - $15.01 $40,293 - $119,764	7,979 Added 8.7%	99,671 $601,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $367,906 - $1.14 Million	58,213 Added 173.88%	91,692 $1.27 Million
Q3 2019 Nov 07, 2019	BUY	$8.03 - $14.82 $110,019 - $203,048	13,701 Added 69.27%	33,479 $280,000
Q2 2019 Aug 12, 2019	BUY	$11.88 - $16.94 $234,962 - $335,039	19,778 New	19,778 $262,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.